Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Antal

Showing results (61-70 of 67) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 67 results.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|June 8, 2025
Pharmacological profiling of major depressive disorder-related multimorbidity clustersTamas Nagy, Xenia Gonda, Andras Gezsi, et al.
Biogerontology|April 5, 2016
Ageing with elegans: a research proposal to map healthspan pathwaysWalter Luyten, Peter Antal, Bart P Braeckman, et al.
Nature Communications|August 21, 2024
Unique genetic and risk-factor profiles in clusters of major depressive disorder-related multimorbidity trajectoriesAndras Gezsi, Sandra Van der Auwera, Hannu Mäkinen, et al.
Alimentary Pharmacology & Therapeutics|December 4, 2025
Serum Villin-1-A Novel Marker of Gut Barrier Damage in Acutely Decompensated Cirrhosis: A Cohort Study and ValidationDavid Tornai, Boglarka Balogh, Aniko Csillag, et al.
Aging|July 8, 2020
Healthspan pathway maps in <i>C. elegans</i> and humans highlight transcription, proliferation/biosynthesis and lipidsSteffen Möller, Nadine Saul, Alan A Cohen, et al.
Molecular & Cellular Proteomics : MCP|May 21, 2023
Large-Scale Plasma Proteome Epitome Profiling is an Efficient Tool for the Discovery of Cancer BiomarkersJozsef Lazar, Peter Antal-Szalmas, Istvan Kurucz, et al.
Journal of Chemical Information and Modeling|August 29, 2023
MELLODDY: Cross-pharma Federated Learning at Unprecedented Scale Unlocks Benefits in QSAR without Compromising Proprietary InformationWouter Heyndrickx, Lewis Mervin, Tobias Morawietz, et al.
Pageof 7

Showing results (61-70 of 67) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 67 results.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|June 8, 2025
Pharmacological profiling of major depressive disorder-related multimorbidity clustersTamas Nagy, Xenia Gonda, Andras Gezsi, et al.
Biogerontology|April 5, 2016
Ageing with elegans: a research proposal to map healthspan pathwaysWalter Luyten, Peter Antal, Bart P Braeckman, et al.
Nature Communications|August 21, 2024
Unique genetic and risk-factor profiles in clusters of major depressive disorder-related multimorbidity trajectoriesAndras Gezsi, Sandra Van der Auwera, Hannu Mäkinen, et al.
Alimentary Pharmacology & Therapeutics|December 4, 2025
Serum Villin-1-A Novel Marker of Gut Barrier Damage in Acutely Decompensated Cirrhosis: A Cohort Study and ValidationDavid Tornai, Boglarka Balogh, Aniko Csillag, et al.
Aging|July 8, 2020
Healthspan pathway maps in <i>C. elegans</i> and humans highlight transcription, proliferation/biosynthesis and lipidsSteffen Möller, Nadine Saul, Alan A Cohen, et al.
Molecular & Cellular Proteomics : MCP|May 21, 2023
Large-Scale Plasma Proteome Epitome Profiling is an Efficient Tool for the Discovery of Cancer BiomarkersJozsef Lazar, Peter Antal-Szalmas, Istvan Kurucz, et al.
Journal of Chemical Information and Modeling|August 29, 2023
MELLODDY: Cross-pharma Federated Learning at Unprecedented Scale Unlocks Benefits in QSAR without Compromising Proprietary InformationWouter Heyndrickx, Lewis Mervin, Tobias Morawietz, et al.
Pageof 7